Reduced Platelet Activity Is Associated With Early Clot Growth and Worse 3-Month Outcome After Intracerebral Hemorrhage
- 1 July 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 40 (7), 2398-2401
- https://doi.org/10.1161/strokeaha.109.550939
Abstract
Background and Purpose— Antiplatelet medication use and reduced platelet activity may be associated with mortality after intracerebral hemorrhage (ICH). We tested the hypothesis that reduced platelet activity is associated with early ICH clot growth and worse outcomes. Methods— We prospectively identified patients with spontaneous ICH, measured platelet activity (VerifyNow-ASA, Accumetrics) on admission, and recorded antiplatelet medication use. ICH volume was calculated using computerized volumetric analysis. Data were analyzed with nonparametric statistics and repeated measures ANOVA as appropriate. Patients were prospectively followed for functional outcomes. Data are presented as mean±SD or median [Q1 to Q3]. Results— Reduced platelet activity (≤550 aspirin reaction units [ARU]) was associated with increased ICH volume growth ( P P =0.001), but without impact on outcomes. Reduced platelet activity was associated with worse modified Rankin Scores at 3 months ( P =0.02). Conclusions— Reduced platelet activity was associated with early ICH volume growth and worse functional outcome. Because platelet activity can be increased with platelet transfusion, increasing platelet activity is a potential method to reduce ICH volume growth and improve functional outcomes.Keywords
This publication has 21 references indexed in Scilit:
- Prior antiplatelet use does not affect hemorrhage growth or outcome after ICHNeurology, 2009
- Off-Hour Admission and In-Hospital Stroke Case Fatality in the Get With The Guidelines-Stroke ProgramStroke, 2009
- Aspirin Responsiveness in Healthy Volunteers Measured with Multiple Assay PlatformsClinical Chemistry, 2008
- Effect of On-Admission Antiplatelet Treatment on Patients with Cerebral HemorrhageCerebrovascular Diseases, 2007
- A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery diseaseEuropean Heart Journal, 2007
- Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical TrialsStroke, 2007
- Dynamics of Intraventricular Hemorrhage in Patients with Spontaneous Intracerebral Hemorrhage: Risk Factors, Clinical Impact, and Effect of Hemostatic Therapy with Recombinant Activated Factor VIINeurosurgery, 2006
- Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generationJournal of Thrombosis and Haemostasis, 2006
- Pretreatment With Antiplatelet Agents Is Not Independently Associated With Unfavorable Outcome in Intracerebral HemorrhageStroke, 2006
- Regular Aspirin-Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for DeathStroke, 2006